need volume, page-4

There have been indeed quite a few share placements inbetween that spike and now, so we are far more diluted.
The run to over 10cents was not only extremely short lived, it was also done on a misconception that PNO had found a cure against pain. The recommmendation causing all this, combined with the ann at the time created a mad flow of trader money into PNO.
I was there, I remember it well.

We are now in a very hostile environment due to US fears of global growth outlook. Investors stay away from risk altogether in the moment, it will be near impossible get any crazy run like that again.
The news expected from PNO are also well anticipated, there won't be any surprises, only the disclosure of details of the expected distribution ann.

I believe that PNO should be trading between 1.8 and 2.2 after news, maybe shortly spiking higher, retreat to 1.5 and settle between 1.5 and 2 cents.
Investors for longer term investment would want to evaluate the company when first earnings will come in from Thermalife sales. Only then will we be able to maintain levels higher than that, in my opinion.

PNO has a long way to go to get away from being a trader stock to become an investor share.
The tripeptofen platform creation will do excactly that for this company whilst Thermalife sales and the upcoming placement will provide the cash flow.

What can propel the shareprice to unexpected heights will be a conceivable chance for a takeover, I always assumed that PNO will be acquired eventually by a larger pharma along the way.